Literature DB >> 9892333

Iatrogenic diseases as a reason for admission to the intensive care unit: incidence, causes, and consequences.

B Darchy1, E Le Mière, B Figuérédo, E Bavoux, Y Domart.   

Abstract

BACKGROUND: Data on iatrogenic diseases (IDs) have been recorded for the past 25 years. We determined whether aging of the general population and medical advances, including more powerful drugs and complex procedures, have altered the incidence, causes, and consequences of severe IDs during this period.
METHODS: One-year retrospective study was conducted in an adult medical-surgical intensive care unit (ICU) affiliated with a French general hospital in an area of 200 000 inhabitants. All the patients admitted to the ICU during 1994 were screened for IDs. Patients with community or hospital-acquired IDs on admission were included. Follow-up assessed morbidity, mortality, workload, and costs of care for IDs, and the rate of preventable IDs. were included; the cause of the ID was drugs in 41, medical acts in 12, and surgical acts in 15. These 68 patients were in the ICU for 472 days, with a 13% fatality rate (9 patients) and a financial cost of US $688 470. They were not different from the 555 other ICU patients in terms of severity, mortality, workload, and length of stay in the ICU. Risk factors for ID were old age and the number of prescribed drugs. The rate of preventable ID was 51%.
CONCLUSIONS: Iatrogenic diseases are a persistent and important reason for admission to the ICU, and the risk factors, causes, and consequences remain unchanged since 1980. Despite 25 years of experience with high-technology medicine, ID still has a negative impact on the health and resources of society.

Entities:  

Mesh:

Year:  1999        PMID: 9892333     DOI: 10.1001/archinte.159.1.71

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  19 in total

1.  Epidemiology of medical error.

Authors:  S N Weingart; R M Wilson; R W Gibberd; B Harrison
Journal:  BMJ       Date:  2000-03-18

2.  Epidemiology of medical error

Authors: 
Journal:  West J Med       Date:  2000-06

3.  Errors in health care management: what do they cost?

Authors:  K D Rigby; J C Litt
Journal:  Qual Health Care       Date:  2000-12

Review 4.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 5.  [Medical emergency teams: current situation and perspectives of preventive in-hospital intensive care medicine].

Authors:  S G Russo; C Eich; M Roessler; B M Graf; M Quintel; A Timmermann
Journal:  Anaesthesist       Date:  2008-01       Impact factor: 1.041

Review 6.  Methods for assessing the preventability of adverse drug events: a systematic review.

Authors:  Katja Marja Hakkarainen; Karolina Andersson Sundell; Max Petzold; Staffan Hägg
Journal:  Drug Saf       Date:  2012-02-01       Impact factor: 5.606

7.  Iatrogenic events contributing to ICU admission: a prospective study.

Authors:  Emmanuelle Mercier; Bruno Giraudeau; Guy Giniès; Dominique Perrotin; Pierre-François Dequin
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

8.  Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study.

Authors:  Lukas Schwake; Ines Wollenschläger; Wolfgang Stremmel; Jens Encke
Journal:  Intensive Care Med       Date:  2008-08-12       Impact factor: 17.440

9.  Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.

Authors:  Marieke Grenouillet-Delacre; Hélène Verdoux; Nicholas Moore; Françoise Haramburu; Ghada Miremont-Salamé; Gabriel Etienne; Philip Robinson; Didier Gruson; Gilles Hilbert; Claude Gabinski; Bernard Bégaud; Mathieu Molimard
Journal:  Intensive Care Med       Date:  2007-07-25       Impact factor: 17.440

10.  Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.

Authors:  Annie Pierre Jonville-Béra; Hassan Saissi; Lamiae Bensouda-Grimaldi; Frederique Beau-Salinas; Haware Cissoko; Bruno Giraudeau; Elisabeth Autret-Leca
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.